Although treatment guidelines recommend initiating an intravenous albumin trial at a dose of 1 g/kg of body weight daily for two consecutive days to restore effective arterial blood volume for AKI in cirrhotic patients [60], administrations of large albumin volumes may not always be advantageous and can potentially induce pulmonary edemas. The gene discussed is ALB; the disease is pulmonary edema.